SCHEMBL25920701

SCHEMBL25920701

COC(=O)c1ccc2c(c1)N(c1ccccc1)C(=O)CS2

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.67
▸ SMN1; SMN2 Q16637 1/20 0.67
▸ ALDH1A1 P00352 7/20 0.52
▸ KDM4E B2RXH2 2/20 0.52
▸ ALOX15 P16050 1/20 0.52
▸ CASP1 P29466 1/20 0.52
▸ CASP7 P55210 1/20 0.52
▸ HSD17B10 Q99714 1/20 0.52
▸ LMNA P02545 3/20 0.51
▸ NPC1 O15118 1/20 0.46
▸ GAA P10253 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ MAPT P10636 1/20 0.43
▸ PMM2 O15305 1/20 0.43
▸ MPI P34949 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ PHOSPHO1 Q8TCT1 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ FGFR1 P11362 1/20 0.42
▸ TP53 P04637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24124284 0.86 LMNA (0.64) POLBSMN1; SMN2ALDH1A1LMNAGAA
SCHEMBL5422370 0.81 POLB (1.00) POLBSMN1; SMN2ALDH1A1KDM4EALOX15
SCHEMBL29978554 0.80 ALDH1A1 (0.64) POLBSMN1; SMN2ALDH1A1LMNANPC1
SCHEMBL21972975 0.80 ALDH1A1 (0.64) POLBSMN1; SMN2ALDH1A1LMNANPC1
SCHEMBL31411690 0.79 SMN1; SMN2 (0.55) POLBSMN1; SMN2ALDH1A1KDM4EALOX15
SCHEMBL8551997 0.78 POLB (0.70) POLBSMN1; SMN2ALDH1A1KDM4EALOX15
SCHEMBL3501542 0.78 NPC1 (0.48) POLBSMN1; SMN2ALDH1A1LMNANPC1
SCHEMBL29978700 0.77 KDM4E (0.67) POLBSMN1; SMN2ALDH1A1KDM4EALOX15
SCHEMBL23769048 0.77 KDM4E (0.67) POLBSMN1; SMN2ALDH1A1KDM4EALOX15
SCHEMBL17276109 0.76 NPC1 (0.46) POLBSMN1; SMN2ALDH1A1LMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242496-A1 SOX11 INHIBITORS FOR TREATING MANTLE CELL LYMPHOMA ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2023-08-03 — — US disclosed
US-20230242496-A1 SOX11 INHIBITORS FOR TREATING MANTLE CELL LYMPHOMA ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2023-08-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242496-A1 SOX11 INHIBITORS FOR TREATING MANTLE CELL LYMPHOMA BCL6, SOX18, BCL3 POLB 2630/4885SMN1; SMN2 4270/4885ALDH1A1 2654/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback